Published in Cell on June 15, 2017
Infectious diseases: Soil-sifting snags new antibiotic. Nat Rev Drug Discov (2017) 0.75
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol (1997) 11.14
Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol (1988) 8.26
Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 7.29
Sequences of the recA gene and protein. Proc Natl Acad Sci U S A (1980) 6.87
Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell (2001) 6.10
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother (2006) 4.19
Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. Proc Natl Acad Sci U S A (1987) 3.80
Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching. Science (2006) 3.76
On fluctuation analysis: a new, simple and efficient method for computing the expected number of mutants. Genetica (1992) 3.54
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother (1996) 3.40
Fluctuation analysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis. Bioinformatics (2009) 3.05
Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell (1996) 2.88
Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell (2005) 2.88
Analysis of the gene encoding the largest subunit of RNA polymerase II in Drosophila. Mol Gen Genet (1989) 2.75
Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst) (2003) 2.52
PhoP-P and RNA polymerase sigmaA holoenzyme are sufficient for transcription of Pho regulon promoters in Bacillus subtilis: PhoP-P activator sites within the coding region stimulate transcription in vitro. Mol Microbiol (1998) 2.45
Structural basis of transcription inhibition by antibiotic streptolydigin. Mol Cell (2005) 2.40
Structural basis of transcription initiation. Science (2012) 2.23
Rifamycins--obstacles and opportunities. Tuberculosis (Edinb) (2010) 2.10
The RNA polymerase "switch region" is a target for inhibitors. Cell (2008) 1.96
Discontinuous movements of DNA and RNA in RNA polymerase accompany formation of a paused transcription complex. Cell (1995) 1.96
Location, structure, and function of the target of a transcriptional activator protein. Genes Dev (1994) 1.88
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res (2009) 1.77
Molecular evolution of multisubunit RNA polymerases: sequence analysis. J Mol Biol (2009) 1.67
Transcription inactivation through local refolding of the RNA polymerase structure. Nature (2008) 1.63
Relationships between bactericidal effect and inhibition of ribonucleic acid nucleotidyltransferase by rifampicin in Escherichia coli K-12. J Bacteriol (1969) 1.47
Response of RNA polymerase to ppGpp: requirement for the omega subunit and relief of this requirement by DksA. Genes Dev (2005) 1.45
Additive effect of tolC and rfa mutations on the hydrophobic barrier of the outer membrane of Escherichia coli K-12. J Bacteriol (1994) 1.43
Lipiarmycin, a new antibiotic from Actinoplanes III. Mechanism of action. J Antibiot (Tokyo) (1975) 1.43
Antibacterial drug discovery in the resistance era. Nature (2016) 1.40
Ordering promoter binding of class III transcription factors TFIIIC1 and TFIIIC2. Mol Cell Biol (1988) 1.30
Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species. Eur J Clin Microbiol Infect Dis (1993) 1.30
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus. Antimicrob Agents Chemother (2009) 1.29
Discrimination against deoxyribonucleotide substrates by bacterial RNA polymerase. J Biol Chem (2004) 1.29
New target for inhibition of bacterial RNA polymerase: 'switch region'. Curr Opin Microbiol (2011) 1.26
Three-dimensional EM structure of an intact activator-dependent transcription initiation complex. Proc Natl Acad Sci U S A (2009) 1.26
Rifamycins LXI: in vivo inhibition of RNA synthesis of rifamycins. Experientia (1968) 1.23
The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). J Antibiot (Tokyo) (1983) 1.22
The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J Antibiot (Tokyo) (1985) 1.20
The involvement of the aspartate triad of the active center in all catalytic activities of multisubunit RNA polymerase. Nucleic Acids Res (2005) 1.19
Antimicrobial Resistance. JAMA (2016) 1.17
Tethering of the large subunits of Escherichia coli RNA polymerase. J Biol Chem (1997) 1.16
The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo) (1995) 1.12
The nucleotide addition cycle of RNA polymerase is controlled by two molecular hinges in the Bridge Helix domain. BMC Biol (2010) 1.11
Fluorescence resonance energy transfer (FRET) in analysis of transcription-complex structure and function. Methods Enzymol (2003) 1.09
GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides. Elife (2014) 1.09
Dominant lethal mutations near the 5' substrate binding site affect RNA polymerase propagation. J Biol Chem (1993) 1.08
An undecamer DNA sequence directs termination of human ribosomal gene transcription. Nucleic Acids Res (1990) 1.07
Transcription inhibition by the depsipeptide antibiotic salinamide A. Elife (2014) 1.06
Bacterial RNA polymerase inhibitors: an organized overview of their structure, derivatives, biological activity and current clinical development status. Curr Med Chem (2009) 1.03
Activity map of the Escherichia coli RNA polymerase bridge helix. J Biol Chem (2011) 0.94
The bridge helix coordinates movements of modules in RNA polymerase. BMC Biol (2010) 0.92
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) (2004) 0.90
Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. II. Structure elucidation. J Antibiot (Tokyo) (1991) 0.86
Chapter 1. Approaches to discovering novel antibacterial and antifungal agents. Methods Enzymol (2009) 0.84
Mild and reversible dehydration of primary amides with PdCl2 in aqueous acetonitrile. Org Lett (2005) 0.84
A kinetic microplate method for quantifying the antibacterial properties of biological fluids. J Microbiol Methods (2003) 0.84
Halogenated spirotetronates from Actinoallomurus. J Nat Prod (2012) 0.84
Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus. J Pharm Pharmacol (2014) 0.83
Diversity of Actinoplanes and related genera isolated from an Italian soil. Microb Ecol (2003) 0.82
Multiple active centers of multi-subunit RNA polymerases. Transcription (2012) 0.82
Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.82
Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. Structure (2015) 0.80
CBR antimicrobials inhibit RNA polymerase via at least two bridge-helix cap-mediated effects on nucleotide addition. Proc Natl Acad Sci U S A (2015) 0.79
Actinobacteria and Myxobacteria-Two of the Most Important Bacterial Resources for Novel Antibiotics. Curr Top Microbiol Immunol (2016) 0.78
Probing of arginine residues in peptides and proteins using selective tagging and electrospray ionization mass spectrometry. J Mass Spectrom (2003) 0.78
The ultraviolet absorption spectra of the pyrimidine ribonucleosides and ribonucleotides. J Biol Chem (1949) 0.78